In MYCN-amplified neuroblastoma, MP1 treatment led to marked destabilization of MYCN protein, accompanied by decreased Mcl-1 expression and induction of autophagic flux, as reflected by increased LC3II accumulation, a widely used marker of autophagosome formation and autophagic activity [28,63]. The gene discussed is MYCN; the disease is neuroblastoma.